Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Whitehawk Therapeutics (WHWK) Interest & Investment Income: 2018-2024

Historic Interest & Investment Income for Whitehawk Therapeutics (WHWK) over the last 7 years, with Dec 2024 value amounting to $3.9 million.

  • Whitehawk Therapeutics' Interest & Investment Income rose 104.19% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.3 million, marking a year-over-year increase of 11.52%. This contributed to the annual value of $3.9 million for FY2024, which is 38.67% down from last year.
  • Whitehawk Therapeutics' Interest & Investment Income amounted to $3.9 million in FY2024, which was down 38.67% from $6.4 million recorded in FY2023.
  • Whitehawk Therapeutics' Interest & Investment Income's 5-year high stood at $6.4 million during FY2023, with a 5-year trough of $13,000 in FY2021.
  • In the last 3 years, Whitehawk Therapeutics' Interest & Investment Income had a median value of $3.9 million in 2024 and averaged $4.2 million.
  • In the last 5 years, Whitehawk Therapeutics' Interest & Investment Income crashed by 96.02% in 2020 and then soared by 18,346.15% in 2022.
  • Whitehawk Therapeutics' Interest & Investment Income (Yearly) stood at $41,000 in 2020, then tumbled by 68.29% to $13,000 in 2021, then spiked by 18,346.15% to $2.4 million in 2022, then spiked by 166.89% to $6.4 million in 2023, then tumbled by 38.67% to $3.9 million in 2024.